Viruses 2014, 6(1), 1-12; doi:10.3390/v6010001

Stem-Cell-Based Gene Therapy for HIV Infection

Department of Medicine, Division of Hematology and Oncology, David Geffen School of Medicine at University of California, Los Angeles, CA 90095, USA
* Author to whom correspondence should be addressed.
Received: 1 November 2013; in revised form: 16 December 2013 / Accepted: 19 December 2013 / Published: 24 December 2013
(This article belongs to the Special Issue Gene Therapy for Retroviral Infections)
PDF Full-text Download PDF Full-Text [705 KB, uploaded 24 December 2013 08:31 CET]
Abstract: Despite the enormous success of combined anti-retroviral therapy, HIV infection is still a lifelong disease and continues to spread rapidly worldwide. There is a pressing need to develop a treatment that will cure HIV infection. Recent progress in stem cell manipulation and advancements in humanized mouse models have allowed rapid developments of gene therapy for HIV treatment. In this review, we will discuss two aspects of HIV gene therapy using human hematopoietic stem cells. The first is to generate immune systems resistant to HIV infection while the second strategy involves enhancing anti-HIV immunity to eliminate HIV infected cells.
Keywords: hematopoietic stem cell; HIV; gene therapy; CCR5; engineered immunity

Article Statistics

Load and display the download statistics.

Citations to this Article

Cite This Article

MDPI and ACS Style

Zhen, A.; Kitchen, S. Stem-Cell-Based Gene Therapy for HIV Infection. Viruses 2014, 6, 1-12.

AMA Style

Zhen A, Kitchen S. Stem-Cell-Based Gene Therapy for HIV Infection. Viruses. 2014; 6(1):1-12.

Chicago/Turabian Style

Zhen, Anjie; Kitchen, Scott. 2014. "Stem-Cell-Based Gene Therapy for HIV Infection." Viruses 6, no. 1: 1-12.

Viruses EISSN 1999-4915 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert